Navellier & Associates’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-34,591
| Closed | -$1.52M | – | 339 |
|
|
2024
Q1 | $1.52M | Buy |
34,591
+26,864
| +348% | +$1.18M | 0.19% | 123 |
|
|
2023
Q4 | $478K | Buy |
+7,727
| New | +$478K | 0.07% | 235 |
|
|
2023
Q1 | – | Sell |
-13,155
| Closed | -$369K | – | 273 |
|
|
2022
Q4 | $369K | Sell |
13,155
-9,436
| -42% | -$264K | 0.08% | 199 |
|
|
2022
Q3 | $635K | Sell |
22,591
-178
| -0.8% | -$5K | 0.14% | 141 |
|
|
2022
Q2 | $792K | Buy |
22,769
+31
| +0.1% | +$1.08K | 0.17% | 134 |
|
|
2022
Q1 | $816K | Buy |
+22,738
| New | +$816K | 0.14% | 139 |
|